• Issues
    • Current Issue
    • Special Issues
  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • HemOnc Link
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Search
  • ASH Home
  • About ASH Clinical News
  • Authors
  • Advertising
  • Subscribe
  • Contact Us
  • eNewsletters
  • Cookie Settings
  • LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
  • Issues
    • AllCurrent IssueSpecial Issues

      April 2021 Volume 7 Issue 5

      March 2021 Special Edition

      March 2021 Volume 7 Issue 4

      February 2021 Volume 7 Issue 3

  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • HemOnc Link
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
    Kevin Brigle, PhD, ANP

    Kevin Brigle, PhD, ANP

    Hematology/Oncology Nurse Practitioner, Massey Cancer Center
    • Bringing Cancer Center Expertise to Rural Hospitals Thursday, August 1st, 2019

      Kevin Brigle, PhD, ANP, describes an outreach program that provides rural communities with access to cancer treatment.

    Sabrina Ahle
    Advertisement

    Current Issue

    April 2021 Volume 7 Issue 5

    Thursday, April 1, 2021
    This issue examines long-haul COVID-19, central nervous system relapse in non-Hodgkin lymphoma, and more.

    Block title

    New Children’s Hospital Coalition Aims to Combat Pandemic-Driven Drug Shortages

    Thursday, April 15, 2021

    Study Finds Children with Down Syndrome Have Higher Risk of AML

    Thursday, April 15, 2021

    Biden Administration Proposes $6.5 Billion Health Research Agency

    Thursday, April 15, 2021

    European Commission Approves Selinexor Plus Dexamethasone for Relapsed/Refractory Myeloma

    Sunday, April 11, 2021

    FDA Approves Isatuximab-irfc Combination for Relapsed/Refractory Myeloma

    Sunday, April 11, 2021
    Recent Posts
    • New Children’s Hospital Coalition Aims to Combat Pandemic-Driven Drug Shortages
    • Study Finds Children with Down Syndrome Have Higher Risk of AML
    • Biden Administration Proposes $6.5 Billion Health Research Agency
    • European Commission Approves Selinexor Plus Dexamethasone for Relapsed/Refractory Myeloma

    Meeting Coverage

    Researchers Validate Burkitt Lymphoma Prognostic Index

    Monday, March 1, 2021

    Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

    Monday, March 1, 2021

    Editor's Corner

    Editor’s Corner: Post-Pandemia Mania

    Thursday, April 1, 2021

    Editor’s Corner: Healing Our Invisible Wounds

    Monday, March 1, 2021
    2021 L Street NW, Suite 900, Washington, DC 20036
    Phone 202-776-0544 | Fax 202-776-0545
    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    Copyright © 2020 by American Society of Hematology

    Contact Us | Terms of Service | Privacy Policy